title: Worsening of thrombotic thromboctyopenic purpura symptoms associated with desmopressin administration.
authors.affiliation: MD Anderson Cancer Centre, Unit 10, 1515 Holcombe Blvd., Houston, Texas 77030, USA. moverman@mdanderson.org
authors.forename: Michael
authors.initials: M
authors.lastname: Overman
authors.forename: Eric
authors.initials: E
authors.lastname: Brass
mesh_terms: D000328:Adult; D000075202:Contraindications; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017713:Platelet Transfusion / Q000009:adverse effects; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D012008:Recurrence; D017211:Treatment Failure
chemical_list: D003894:Deamino Arginine Vasopressin